The FDA has approved Allergan’s Natrelle Inspira SoftTouch breast implants. Two double-blind, placebo-controlled Phase 3 trials are now underway to evaluate daxibotulinumtoxinA (RT002) from Revance Therapeutics for the treatment of glabellar lines. Also, Venus Concept is bringing its Venus Velocity diode laser to the US for hair removal and Olay and 23andMe teamed up to determine if nature or nurture contributes more to a youthful appearance. Plus, Modern Aesthetics co-chief medical editors want to know what your goals are for 2017.
2004 video views since 1/30/2017